Gadolinium in Humans: A Family of Disorders.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27224028.
- Also identified by DOI 10.2214/AJR.15.15842.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The literature informs us that gadolinium can cause health issues. At least four major gadolinium disorders, including the two well-recognized nephrogenic systemic fibrosis and severe acute adverse event, have been identified. We propose naming the histopathologically proven presence of gadolinium in brain tissue "gadolinium storage condition," and we describe a new entity that represents symptomatic deposition of gadolinium in individuals with normal renal function, for which we propose the designation "gadolinium deposition disease."
Medical subject headings
- Brain Diseases
- Drug-Related Side Effects and Adverse Reactions
- Gadolinium
- Nephrogenic Fibrosing Dermopathy